PNP Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PNP Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10864
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PNP Therapeutics Inc (PNP Therapeutics) is a clinical-stage biopharmaceutical company that develops platform technology and products for the treatment of cancer. The company develops products for various types of cancer such as prostate, breast, colon, lung, brain, melanoma, kidney, ovarian, pancreas and chronic lymphocytic leukemia, among others. It provides E. coli purine nucleoside phosphorylase enzyme, which is used to kill the entire tumor mass of well-characterized nucleoside prodrugs generating active metabolites with high levels of anti-tumor activity. The company caters its services to various medical universities. PNP Therapeutics is headquartered in Birmingham, Alabama, the US.

PNP Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PNP Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PNP Therapeutics Raises USD0.1 Million in Venture Financing 10
PNP Therapeutics Raises USD0.3 Million in Financing Round 11
PNP Therapeutics Raises USD0.3 Million in Financing 12
PNP Therapeutics Raises USD0.4 Million in Financing Round 13
PNP Therapeutics Raises USD0.2 Million in Financing Round 14
PNP Therapeutics Raises USD0.7 Million in Financing Round 15
PNP Therapeutics Inc – Key Competitors 16
PNP Therapeutics Inc – Key Employees 17
PNP Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PNP Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PNP Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PNP Therapeutics Raises USD0.1 Million in Venture Financing 10
PNP Therapeutics Raises USD0.3 Million in Financing Round 11
PNP Therapeutics Raises USD0.3 Million in Financing 12
PNP Therapeutics Raises USD0.4 Million in Financing Round 13
PNP Therapeutics Raises USD0.2 Million in Financing Round 14
PNP Therapeutics Raises USD0.7 Million in Financing Round 15
PNP Therapeutics Inc, Key Competitors 16
PNP Therapeutics Inc, Key Employees 17

List of Figures
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PNP Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PNP Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Golden Minerals Company:企業の戦略・SWOT・財務分析
    SummaryGolden Minerals Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Nabors Industries, Ltd. (NBR):企業のM&A・提携動向(石油・ガス分野)
    Summary Nabors Industries, Ltd. (Nabors) is an oil and gas contract services provider. It offers offshore platform work over and drilling rigs; and completion and production services such as, hydraulic fracturing, cementing, nitrogen and acid pressure pumping services. It offers a wide range of anci …
  • International Vaccine Institute(製薬・医療分野):企業M&A動向
    Summary International Vaccine Institute (IVI) is an international nonprofit organization. The company conducts research, development, and production of vaccines. Its vaccine portfolio includes Killed whole-cell oral cholera vaccine, Bivalent enteric fever conjugate vaccine, Vi polysaccharide typhoid …
  • Relentless Resources Ltd. (RRL):企業の財務及び戦略的SWOT分析
    Summary Relentless Resources Ltd. (RRL) is an oil and gas company that offers exploration services. The company acquires, develops, explores, and produces crude oil and natural gas in Alberta and Saskatchewan. Its properties include Willesden Green, Heathdale, Niton and Loverna; and holds assets in …
  • Cardinal Health Inc (CAH):企業のM&A・提携動向(医療分野)
    Summary Cardinal Health Inc (Cardinal Health) offers medical-surgical products, equipment, and pharmaceutical and medical products. It distributes branded and generic pharmaceutical; and specialty pharmaceutical products; over-the-counter healthcare and consumer products; medical equipment; surgical …
  • Ardent Leisure Limited (formerly Macquarie Leisure Trust Group):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ardent Leisure Limited (formerl …
  • Ansys, Inc.の企業概要及び財務/SWOT分析
    Ansys, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Ansys, Inc. annual and quarterly forecasts made by stock market experts. The report also enables direct comparison …
  • Allianz Saudi Fransi Cooperative Insurance Company:企業の戦略・SWOT・財務分析
    SummaryAllianz Saudi Fransi Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 36 …
  • Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析
    Summary Catalyst Biosciences Inc (Catalyst), formerly Targacept Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address hematology indications. The company discovers and develops next generation biopharmaceuticals based on engineered human proteases platform techno …
  • PUC Founder (MSC) Berhad (PUC):企業概要、財務及び戦略的SWOT分析
    Summary PUC Founder (MSC) Berhad (PUC Founder) is an information technology company. The company develops fingerprint security system. Its products include DocDefend, EagleAGS, EagleCTP, EagleDOT, EagleProof, EagleRIP, EagleROC and EagleSuperline. Its DocuDefend serves government departments, civil …
  • Manac Incorporated (4364):企業概要、財務及び戦略的SWOT分析
    Summary Manac Incorporated (Manac) is a manufacturing company. The company supplies flame retardants, pharmaceuticals, pharmaceuticals for animals. Its product categories are divided into three types: flame retardants, inorganic chemicals and organic chemicals. Manac's inorganic compounds include in …
  • SMBC Consumer Finance Co., Ltd. (8574):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "SMBC Consumer Finance Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric st …
  • Fresenius Kabi USA LLC:企業の戦略的SWOT分析
    Fresenius Kabi USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • California Cryobank:製薬・医療:M&Aディール及び事業提携情報
    Summary California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, …
  • MESCO, Inc.:企業の戦略・SWOT・財務分析
    SummaryMESCO, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Canadian Real Estate Investment Trust:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Canadian Real Estate Investment …
  • Quantum Utility Generation LLC:電力:M&Aディール及び事業提携情報
    Summary Quantum Utility Generation LLC (QUG) is an electric utility that acquires, develops, operates and optimizes power generation assets in the Americas. The utility generates electricity from various sources such as wind, coal and natural gas-based power generation plants. It also produces elect …
  • Dios Exploration Inc. (DOS):企業概要、財務及び戦略的SWOT分析
    Summary Dios Exploration Inc. (DEI) is a mineral exploration company. The company acquires, explores and develops mineral deposits such as gold and diamond. It explores glacial terranes by sampling glacial sediment cover for minerals. DEI's properties include AU33 (gold-diamonds), Shipshaw carbonati …
  • Taekwang Industrial Co., Ltd. (003240):企業財務及び戦略的SWOT分析
    Summary Taekwang Industrial Co., Ltd. (Taekwang) is a chemical company that manufacturers and markets petrochemical, fiber and textile, and advanced materials. The company offers products such as purified terephthalic acid, propylene, acrylonitrile, sodium cyanide, ammonium sulphate, acetonitrile, h …
  • Itamar Medical Ltd. (ITMR):企業概要、財務及び戦略的SWOT分析
    Summary Itamar Medical Ltd. (Itamar Medical) is a bio-medical technology company. It undertakes the development, marketing and distribution of diagnostic medical devices. The company’s products are developed based on PAT (Peripheral Arterial Tone) signal technology. Its PAT signal is a non-invasive …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆